acetohydroxamic acid has been researched along with Libman-Sacks Disease in 1 studies
acetohydroxamic acid: urease inhibitor
oxime : Compounds of structure R2C=NOH derived from condensation of aldehydes or ketones with hydroxylamine. Oximes from aldehydes may be called aldoximes; those from ketones may be called ketoximes.
N-hydroxyacetimidic acid : A carbohydroximic acid consisting of acetimidic acid having a hydroxy group attached to the imide nitrogen.
acetohydroxamic acid : A member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sim, E | 1 |
| Jones, A | 1 |
| Stanley, L | 1 |
1 other study available for acetohydroxamic acid and Libman-Sacks Disease
| Article | Year |
|---|---|
Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
Topics: Animals; Complement C3; Complement C4; Guinea Pigs; Humans; Hydroxamic Acids; Lupus Erythematosus, S | 1985 |